DS

Digambar Singh

Active Director Director DIN 00941975
DIN 00941975 First appointment Feb 2003 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2003
Shareholding value •••• Premium profile

About Digambar Singh

Data last updated:

Digambar Singh is a Director at Lexica Drugs And Formulations Private Limited (since 2003). The company operates in Chemicals. Lexica Drugs And Formulations Private Limited reported revenue of ₹4.7 Lakh (FY 2025).

DIN 00941975
Primary Designation Director
Industry Chemicals
First Appointment 05 Feb 2003
Oldest Company Age 23 yrs
Largest company Lexica Drugs And Formulations Private Limited · ₹4.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Feb 20032003₹4.7 Lakh (FY 2025)Active

Board colleagues of Digambar Singh

NameDINCompanyDesignation
Neelu Rani Singh00941936Lexica Drugs And Formulations Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lexica Drugs And Formulations Private Limited
Premium access

Shareholding and investment profile for Digambar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Digambar Singh

Digambar Singh currently holds 1 directorship: Lexica Drugs And Formulations Private Limited (Director, since 05 Feb 2003, revenue ₹4.7 Lakh (FY 2025)).

Digambar Singh was first appointed on 05 Feb 2003 as Director at Lexica Drugs And Formulations Private Limited.

The current boards of Digambar Singh's companies include Neelu Rani Singh (Lexica Drugs And Formulations Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available